The Marodyne LiV device is medically certified to combat osteoporosis, build bone density, and improve blood flow.
Professor Clinton Rubin’s Research
Over 35 years of research led to the development of Low-intensity Vibration (LiV) therapy and the Marodyne LiV device.
Royal Osteoporosis Society
MyBones is a proud supporter of the Royal Osteoporosis Society. For more information or to join as a member, visit www.theros.org.uk or Freephone 0808 800 003.
The ROS is a registered charity. Charity No. 11002712
People the world over have experienced the benefits of Marodyne LiV with many regaining their independence, flexibility and freedom. Marodyne LiV emits precisely calibrated, Low-intensity Vibrations to stimulate the bone-forming processes within the mesenchymal stem cells. It’s a 100% natural way to combat osteoporosis. Thousands of people around the world can now do the things they love for longer.
Find out more >
Patricia Cox, 71, High Wycombe
Dorothy Wood, 72, Sheffield
Danah Witkin, 57, London
Trevor Dyson, 66, Northamptonshire
Lis Harding, 79, Chester
Mavis Ahern, 73, Brecon
Geraldine Chamberlain, 67, Colchester
Lesley Wilkinson, 65, Ripon, North Yorkshire
Julie Arnold, 65, Beaconsfield
Judith Darling, 58, Shropshire
Fractures represent an enormous cost to UK healthcare providers and, in many cases, they could be avoided with better preventative treatments.
Osteoporosis already affects millions of people in the UK, with that number only set to rise as the population ages.
A drop in the body’s oestrogen levels during menopause means women are at an increased risk of losing bone density
Women are at an increased risk of osteoporosis
We can’t ignore the damaging impact osteoporosis has on women’s lives
Up to 80% of us will experience osteoporosis in our lifetimes
To protect patients and healthcare providers, we need to focus on preventing the causes of osteoporosis, not treating the outcomes
